ENTITY

Curis Inc (CRIS US)

Analysis

Health Care • United States

Curis, Inc. operates as a biotechnology company. The Company develops therapeutics for the regeneration and restoration of human tissues and organs. Curis offers drug candidates for the treatment of human cancers. Curis serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00